Dr. Garzone is a board member of the National Foundation for Cancer Research and a renowned drug development and leadership executive. She has successfully managed multiple regulatory approvals and INDs in different therapeutic dossiers. Her resume includes multiple FDA approvals, dozens of peer review co-authorships, and 100’s of millions in value creation from pre-clinical stage to drug development. She routinely interacts with FDA advisory committees, health authorities (US, CHMP, PMDA, HC) for pre-IND reviews, EOP2 meetings, and EMEA scientific advisory meetings. She is the co-chair of AIM-HI Women’s Venture Competition.